BioWorld

April 16, 2007

View Archived Issues

Senate HELP Panel To Review Comprehensive FDA Measure

WASHINGTON - Wide-ranging FDA legislation is scheduled for Senate review on Wednesday, but notably, the bill does not include a provision related to follow-on biologics. (BioWorld Today) Read More

Dyax Gets Boost From Positive Phase III Data Of DX-88 In HAE

Read More

In Down's, A Narrow Solution To A Broad Learning Problem

Read More

Novelos' Financing To Garner $15M For Lung Cancer, Hep C

Read More

Clinic Roundup

Read More

Other News To Note

Read More

Appointments And Advancements

Read More